Morgan Stanley
—Price / book
Market cap
—
Tangible equity (USD)
$88.90B
Price / tangible book
—
Price / book
—
Net income / ending equity
15.1%
Net income / ending assets
1.2%
Efficiency ratio
—
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: MS stock price vs VRTX: inconclusive — current versus $346.23 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at VRTX's multiple
Implied fair value · at MS's multiple
Needs MS P/E.
Snapshot Sep 14, 2026, 4:00 PM ET
Metric by metric
Filter, sort, and scan the equity metrics that matter most for banks: book value, tangible book, returns, and operating efficiency.
Lower is better
Lower is better
Profitability lag
Asset efficiency lag
Lower is better
Statements
Reported bank earnings and balances, with each company’s reporting period shown.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
16 period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
Tangible book and profitability anchor a bank, not enterprise value.
Deposits and cash-like balances distort enterprise value for banks, so this section reads equity value, tangible book and profitability instead.
Price / book
Market cap
—
Tangible equity (USD)
$88.90B
Price / tangible book
—
Price / book
—
Net income / ending equity
15.1%
Net income / ending assets
1.2%
Efficiency ratio
—
Price / tangible book
Market cap
$131.68B
Tangible equity (USD)
$17.15B
Price / tangible book
7.68x
Price / book
7.05x
Net income / ending equity
21.2%
Net income / ending assets
15.4%
Efficiency ratio
—
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
MORGAN STANLEY · implied price per share
Bank model off — standard DCF modelling is disabled for financial institutions.
VERTEX PHARMACEUTICALS INC / MA · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider banking comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
The Goldman Sachs Group, Inc.
MS vs GS
JPMorgan Chase & Co.
MS vs JPM
Bank of America Corporation
MS vs BAC
Citigroup Inc.
MS vs C
SCHWAB CHARLES CORP
MS vs SCHW
Wells Fargo & Company
MS vs WFC
AMGEN INC
MS vs AMGN
Gilead Sciences, Inc.
MS vs GILD
BIOGEN INC.
MS vs BIIB
Moderna, Inc.
MS vs MRNA
Illumina, Inc.
MS vs ILMN
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.